Your browser doesn't support javascript.
loading
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.
Kokudo, Norihiro; Takemura, Nobuyuki; Hasegawa, Kiyoshi; Takayama, Tadatoshi; Kubo, Shoji; Shimada, Mitsuo; Nagano, Hiroaki; Hatano, Etsuro; Izumi, Namiki; Kaneko, Shuichi; Kudo, Masatoshi; Iijima, Hiroko; Genda, Takuya; Tateishi, Ryosuke; Torimura, Takuji; Igaki, Hiroshi; Kobayashi, Satoshi; Sakurai, Hideyuki; Murakami, Takamichi; Watadani, Takeyuki; Matsuyama, Yutaka.
Afiliação
  • Kokudo N; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Takemura N; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Hasegawa K; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Takayama T; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Kubo S; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Shimada M; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Nagano H; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Hatano E; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Izumi N; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Kaneko S; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Kudo M; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Iijima H; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Genda T; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Tateishi R; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Torimura T; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Igaki H; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Kobayashi S; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Sakurai H; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Murakami T; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Watadani T; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
  • Matsuyama Y; The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
Hepatol Res ; 49(10): 1109-1113, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31336394
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article